⌘K

Login Start Free

Home/Filings/4/0001140361-23-009492

4//SEC Filing

Myint Han 4

Accession 0001140361-23-009492

CIK 0001661059other

View on SEC.gov Company Profile

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 6:01 PM ET

Size

5.0 KB

Accession

0001140361-23-009492

Insider Transaction Report

Form 4

Period: 2023-02-28

NextCure, Inc.NXTC

Chief Medical Officer

Transactions

Award
Employee Stock Option (Right to Buy)
2023-02-28+135,000→ 135,000 total
Exercise: $1.55Exp: 2033-02-27→ Common Stock (135,000 underlying)

Footnotes (1)

[F1]One fourth of the option vests on February 28, 2024. The remainder vests in 36 monthly installments beginning on March 28, 2024.

Documents

1 file

4
form4.xmlPrimary

Issuer

NextCure, Inc.

CIK 0001661059

Entity typeother

Related Parties

1

filerCIK 0001840942

Filing Metadata

Form type: 4
Filed: Feb 28, 7:00 PM ET
Accepted: Mar 1, 6:01 PM ET
Size: 5.0 KB

View on SEC.gov